Linda Zangwill, Carl Zeiss Meditec Inc (F), Heidelberg Engineering GmbH (F), Nidek Inc (F), Optovue Inc (F), Quark (F), Topcon Medical Systems Inc (F);
Naira Khachatryan, None;
Christopher Bowd, None;
Jeffrey Liebmann, Alcon Laboratories, Inc (C), Allergan Inc (C), Allergan Inc (F), Bausch & Lomb (C), Bausch & Lomb (F), Carl Zeiss Meditec (F), Diopysis Inc (C), Diopysis Inc (F), Heidelberg Engineering GmbH (C), Heidelberg Engineering GmbH (F), Merz Pharmaceuticals Inc (C), Optovude Inc (F), Quark Pharmaceuticals Inc (F), Reichert Inc (F), Sensimed Inc (F), Topcon Inc (F), Valeant Pharmaceuticals Inc (C);
Christopher Girkin, Carl Zeiss Meditec Inc (F), EyeSight Foundation of Alabama (F), Heildeberg Engineering, GmbH (F), National Eye Institute (F), Research to Prevent Blindness (F), SOLX (F);
Robert Weinreb, Aerie (F), Alcon (C), Allergan (C), Amatek (C), Aquesys (C), Bausch & Lomb (C), Carl Zeiss Meditec (C), Carl Zeiss Meditec (F), Genentech (F), Heidelberg Engineering GmbH (F), Nidek Inc (F), Novartis (F), Optovue (F), Topcon (C), Topcon (F), Valeant (C);
Pamela Sample, None;
Naama Hammel, None;
Lucie Sharpsten, None;
Felipe Medeiros, Alcon Laboratories (R), Alcon Laboratories, Inc (F), Allergan (C), Allergan Inc (F), Allergan Inc (R), Bausch & Lomb (F), Carl Zeiss Meditec Inc (C), Carl Zeiss Meditec Inc (F), Carl Zeiss Meditec Inc (R), Heidelberg Engineering Inc (F), Merck Inc (F), National Eye Institute (F), Novartis (C), Reichert Inc (F), Reichert Inc (R), Sensimed (F), Topcon Inc (F)